We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPLN
351
Openlane
OPLN
$4.28B
| $10.5M | 0.02% |
896,327
-467,740
| -34% | -$7.02M |
|
|
PRSU
352
Pursuit Attractions and Hospitality Inc
PRSU
$1.47B
| $10.2M | 0.02% |
316,685
+7,926
| +3% | +$277K |
|
353
Webster Financial
WBS
$12.5B
| $10.2M | 0.01% |
221,404
-9,629
| -4% | -$446K |
|
354
Minerals Technologies
MTX
$2.36B
| $10.1M | 0.01% |
201,978
-6,442
| -3% | -$392K |
|
355
Americold
COLD
$4.19B
| $10M | 0.01% |
406,943
-854,472
| -68% | -$25.8M |
|
|
SCS
356
DELISTED
Steelcase
SCS
| $9.64M | 0.01% |
1,449,892
-103,576
| -7% | -$1.11M |
|
357
Assurant
AIZ
$13.9B
| $9.6M | 0.01% |
66,570
-3,685
| -5% | -$602K |
|
358
Microsoft
MSFT
$2.96T
| $9.42M | 0.01% |
41,029
+1,277
| +3% | +$337K |
|
359
Silvercrest Asset Management
SAMG
$80.4M
| $9.19M | 0.01% |
561,827
-16,097
| -3% | -$287K |
|
|
SIX
360
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.08M | 0.01% |
+495,107
| New | +$11.2M |
|
361
First Citizens BancShares
FCNCA
$25B
| $9.01M | 0.01% |
11,268
-2,605
| -19% | -$2.04M |
|
|
CTRA
362
DELISTED
Coterra Energy
CTRA
| $8.96M | 0.01% |
342,834
+103,494
| +43% | +$2.96M |
|
363
Meritage Homes
MTH
$4.97B
| $8.89M | 0.01% |
250,160
-300,458
| -55% | -$12.2M |
|
|
ACRE
364
Ares Commercial Real Estate
ACRE
$257M
| $8.86M | 0.01% |
824,466
-24,343
| -3% | -$315K |
|
365
CRA International
CRAI
$1.17B
| $8.85M | 0.01% |
99,678
-3,208
| -3% | -$294K |
|
366
British American Tobacco
BTI
$134B
| $8.77M | 0.01% |
246,906
+95,388
| +63% | +$3.82M |
|
367
Hershey
HSY
$36.8B
| $8.72M | 0.01% |
39,546
+7,750
| +24% | +$1.74M |
|
368
Pinnacle West Capital
PNW
$12.9B
| $8.38M | 0.01% |
129,392
-8,184
| -6% | -$603K |
|
369
DNOW Inc
DNOW
$2.55B
| $8.22M | 0.01% |
+746,166
| New | +$8.07M |
|
370
Maximus
MMS
$3.31B
| $7.91M | 0.01% |
135,596
-1,794
| -1% | -$112K |
|
371
Vermilion Energy
VET
$1.58B
| $7.88M | 0.01% |
266,406
+215,328
| +422% | +$5.05M |
|
372
Ashland
ASH
$3.13B
| $7.77M | 0.01% |
80,942
-15,658
| -16% | -$1.59M |
|
373
Midland States Bancorp
MSBI
$707M
| $7.64M | 0.01% |
324,135
-43,617
| -12% | -$1.13M |
|
374
Ingredion
INGR
$6.43B
| $7.44M | 0.01% |
91,308
-5,718
| -6% | -$502K |
|
|
HOLX
375
DELISTED
Hologic
HOLX
| $6.92M | 0.01% |
106,648
-5,643
| -5% | -$391K |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.